Mitoquinone Prevents Cardiac Dysfunction by Normalizing Mitochondrial ROS and Calcium Handling in Acute Myocardial Infarction
Acta Physiologica · 2026-08 · 242 (8)
DOI: 10.1111/apha.70276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 10.07.2026. Verfasst von Carolina Falcão Ximenes und 14 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduate Program in Physiological Sciences, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil. Hauptthemen laut MEDLINE: Ubiquinone, Myocardial Infarction, Organophosphorus Compounds, Reactive Oxygen Species. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research and Innovation Support (FAPES), National Council for Scientific and Technological Development (CNPq)- Brazil, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Acute myocardial infarction (MI) is the leading cause of heart failure (HF). However, the role of mitochondrial ROS (ROSm) in early MI dysfunction remains unclear. This study aimed to evaluate the impact of MitoQ on cardiac function in cases of heart HF following MI. Male Wistar rats were divided into four experimental groups: Sham, Infarct, Sham+MitoQ, and Infarct+MitoQ. MitoQ was administered orally (8 mg/kg/dia) for 7 days. Hemodynamic parameters, infarct area, papillary muscle contractility, cardiomyocyte mechanics, Ca 2+ transients, and total and mitochondrial superoxide (DHE and MitoSOX) were assessed. After 7 days of MI, rats exhibited impaired contractility, altered inotropic response to extracellular Ca 2+ , cardiomyocyte hypertrophy, and increased total and ROSm. MitoQ prevented body weight loss and significantly improved hemodynamic parameters compared to the Infarct group. In papillary muscles, MitoQ restored basal isometric force and the inotropic response to extracellular Ca 2+ . In cardiomyocytes, it attenuated hypertrophy, preserved shortening, and reduced ([Ca 2+ ]i) transient amplitude. MitoQ significantly decreased total and mitochondrial O 2 • − production. It selectively reduced NOX1 expression under simulated conditions but did not significantly affect NOX2, SOD1, or catalase expression in the context of MI. MitoQ prevented contractile dysfunction, suggesting that mitochondrial oxidative stress plays a decisive role in myocardial dysfunction during the acute phase of MI. Targeting antioxidant therapy to the mitochondria represents a promising strategy for preventing post‐infarction heart failure and opens new perspectives for the development of more effective interventions in the treatment of cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Post-Graduate Program in Physiological Sciences, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.
- Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
- Department of Pharmacology, University of California Davis, Davis, California, USA.
- Department of Morphology, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.
ORCID-Profile: Carolina Falcão Ximenes, Carmen Castardeli, Katyana Kaline Silva Ferreira, Anna Karolina Nascimento Costa, Mario Morais Silva, Sérgio Ricardo Aluotto Scalzo, Marcos Eliezeck, Silvia Guatimosim, Eduardo Hertel Ribeiro, Donald M Bers, Aurélia Araujo Fernandes, Ivanita Stefanon
Förderung
- Foundation for Research and Innovation Support (FAPES)
- National Council for Scientific and Technological Development (CNPq)- Brazil
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Fundação de Amparo à Pesquisa e Inovação do Espírito Santo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Ximenes, C. F., Lorencini, P. Z., Castardeli, C., Machado, M. R. R., Ferreira, K. K. S., Mendes, S. B. O., Costa, A. K. N., Silva, M. M., Scalzo, S. R. A., Eliezeck, M., Guatimosim, S., Ribeiro, E. H., Bers, D. M., Fernandes, A. A., & Stefanon, I. (2026). Mitoquinone Prevents Cardiac Dysfunction by Normalizing Mitochondrial ROS and Calcium Handling in Acute Myocardial Infarction. Acta Physiologica, 242(8). https://doi.org/10.1111/apha.70276
Vancouver
Ximenes CF, Lorencini PZ, Castardeli C, Machado MRR, Ferreira KKS, Mendes SBO, et al. Mitoquinone Prevents Cardiac Dysfunction by Normalizing Mitochondrial ROS and Calcium Handling in Acute Myocardial Infarction. Acta Physiologica. 2026;242(8). doi:10.1111/apha.70276
BibTeX
@article{Ximenes2026,
author = {Ximenes, Carolina Falcão and Lorencini, Pietra Zava and Castardeli, Carmen and Machado, Marlon Ramos Rosado and Ferreira, Katyana Kaline Silva and Mendes, Sara Bianca Oliveira and Costa, Anna Karolina Nascimento and Silva, Mario Morais and Scalzo, Sérgio Ricardo Aluotto and Eliezeck, Marcos and Guatimosim, Silvia and Ribeiro, Eduardo Hertel and Bers, Donald M and Fernandes, Aurélia Araujo and Stefanon, Ivanita},
title = {Mitoquinone Prevents Cardiac Dysfunction by Normalizing Mitochondrial ROS and Calcium Handling in Acute Myocardial Infarction},
journal = {Acta Physiologica},
year = {2026},
volume = {242},
number = {8},
doi = {10.1111/apha.70276}
}
EUVIMED